Gastrointestinal bleeding. Gastrointestinal bleeding risk is increased by novel anticoagulants
- PMID: 25601661
- DOI: 10.1038/nrgastro.2015.7
Gastrointestinal bleeding. Gastrointestinal bleeding risk is increased by novel anticoagulants
Abstract
A report has demonstrated that in patients with atrial fibrillation the novel oral anticoagulant, dabigatran, increases the risk of gastrointestinal bleeding by nearly twofold compared with warfarin. Here, the risk of gastrointestinal bleeding associated with anticoagulants and antiplatelet agents is placed into clinical context and key management principles are emphasized.
Comment on
-
Risk of bleeding with dabigatran in atrial fibrillation.JAMA Intern Med. 2015 Jan;175(1):18-24. doi: 10.1001/jamainternmed.2014.5398. JAMA Intern Med. 2015. PMID: 25365537 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical